Accès ouvert
2026
article
OpenAlex
My Ngoc Ha, Raphaël Thuillet, Mina Ottaviani, Corinne Normand et autres
AIMS: Pulmonary arterial hypertension (PAH) is a progressive cardiopulmonary disorder marked by pulmonary vascular remodelling and vessel loss, paradoxically occurring despite high VEGF signaling. While VEGF/VEGFR pathways are implicated in disease pathogenesis, their role in endothelial and immune cell crosstalk remains poorly …
fr
(code pays fourni par la source)
2026
article
OpenAlex
Sara Abd Al Rahim, Bruno Ribeiro Baptista, Huguette Louis, Cécile V. Denis et autres
Sara Abd Al Rahim, Bruno Ribeiro Baptista, Huguette Louis, Cécile V Denis, Christophe Guignabert, Ly Tu, Véronique Regnault, Patrick Lacolley, Julien Perri
fr
(code pays fourni par la source)
2026
article
OpenAlex
Nan Zheng, Ly Tu, Pu Xu, Rongfang Chen et autres
Harnessing the simultaneous activation of GLP-1R, GIPR, and GCGR has emerged as a highly promising therapeutic paradigm for obesity and related metabolic diseases, including nonalcoholic steatohepatitis (NASH). Here, we report the discovery of TPM003, a novel unimolecular GLP-1R/GIPR/GCGR triple agonist engineered by …
cn, nl, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Matthieu Leuillier, Mustapha Kamel Chelgham, Hind Messaoudi, Ly Tu et autres
INTRODUCTION: Pulmonary hypertension (PH) is a severe cardiovascular disorder characterized by elevated pulmonary artery pressure caused by remodeling of the pulmonary circulation. This study aimed to investigate the role of the soluble epoxide hydrolase phosphatase domain (sEH-P) in PH pathogenesis. METHODS: The …
fr, de, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Clarissa Becher, E. Groeneveld, Rozenn Quarck, Beau Neep et autres
BACKGROUND: Pulmonary arterial hypertension (PAH) is a progressive disorder involving disrupted BMP (bone morphogenetic protein) signaling, pulmonary inflammation, and endothelial-to-mesenchymal transition (EndMT). We hypothesized that IL (interleukin)-33 signaling contributes to PAH progression by inducing EndMT and interacting with BMP9, a key modulator …
nl, be, us, de, fr, es
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Gonçalo Boleto, Anne Cauvet, Christophe Guignabert, Raphaël Thuillet et autres
BACKGROUND: Interleukin-2-inducible T cell kinase (ITK) is a tyrosine kinase involved in T cell activation, differentiation, and receptor signaling. Soquelitinib (SQL) is a selective, covalent inhibitor of ITK. The abnormal activation of T cells plays a key role in the early inflammatory …
pt, fr, us
(code pays fourni par la source)
2025
article
OpenAlex
Ly Tu, Renjie Huang, Qian Yin, Chao Li et autres
cn
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Ross Jones, Eckart M. D. D. De Bie, Nina Deliu, AYKC Ng et autres
Pulmonary arterial hypertension (PAH) is a rare, life-limiting disease where imbalances in the TGFb superfamily pathways have causal roles in hereditary and idiopathic forms. These pathways are emerging attractive candidates for therapeutic intervention but there is an unmet need for clinically relevant …
gb, fr, us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
R. Jones, Eckart M. D. D. De Bie, Nina Deliu, Chi‐Fai Ng et autres
Pulmonary arterial hypertension (PAH) is a rare, life-limiting disease where imbalances in the TGFb superfamily pathways have causal roles in hereditary and idiopathic forms. These pathways are emerging attractive candidates for therapeutic intervention but there is an unmet need for clinically relevant …
gb, fr, us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Laurent Savale, Athénaïs Boucly, Jérémie Pichon, Anne Roche et autres
Managing acute decompensated pulmonary hypertension (PH) is challenging, requiring a multidisciplinary approach. However, prospective data on prognostic factors remain scarce. Aims: The ProPULS study evaluated survival in patients admitted with acute decompensation of pulmonary arterial hypertension (PAH) or chronic thromboembolic PH (CTEPH) …
fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Aliaume Le Pape, Christophe Guignabert, Ly Tu, Nathalie Mougenot et autres
Pulmonary hypertension (PH) is a progressive condition characterized by muscularization of precapillary arteries, chronic inflammation, and a loss of the distal pulmonary circulation. These changes can be mimicked in rats by monocrotaline (MCT) administration. The impact of MCT-induced pulmonary damage on ventilatory …
fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Zongye Cai, Ly Tu, Siyu Tian, Lin Deng et autres
Background Activation of the plasma kynurenine pathway (KP) may contribute to the progression of pulmonary arterial hypertension (PAH). We investigated the functional role and molecular mechanisms of KP activation in PAH. Methods KP activity was measured in the lungs and plasma of …
nl, cn, fr, se, at, it, de, sk
(code pays fourni par la source)